There’s hope for men who can’t keep “releasing” themselves. You know, like this guy:
From ABC News:
Researchers found that men with primary premature ejaculation who used an experimental topical spray called PSD502 had ejaculation times more than five times longer than men who used a placebo spray. PSD502 is a combination of two common numbing agents – lidocaine and prilocaine.
“Combined results from the PS502 pivotal studies are very exciting and this is a significant milestone,” said Dr. Ira Sharlip, lead investigator and clinical professor of urology at the University of California, San Francisco in a press release.
“I’m really hopeful and optimistic, because there isn’t really an existing behavioral therapy technique that works out there,” he said.
“The data look very solid. The men had increased latency times that looked clinically relevant,” said Dr. Anthony Smith , professor and chief of the division of urology at the University of New Mexico.
Please take note that this has not (yet) been approved by the U.S. Food and Drug Administration. If approved, it would help the estimated 30 percent of men from the ages of 18 to 59 who suffer from premature ejaculation.
For more male health issues related to this topic:
Bad Side Effects of Viagra, Cialis, Levitra
Are Lupron, Vintas, Other Prostrate-Cancer Drugs Safe?
